Pharmaceuticals, Biotechnology and Life Sciences
Basilea Pharmaceutica Ltd. has reported that preclinical data on the single agent anti-cancer activity of the drug candidate BAL0891 have been presented at the Targeted Anticancer Therapies congress 2022 of the European Society of Medical Oncology (ESMO TAT 2022), which is taking place online March 7-8, 2022.
NEC OncoImmunity (NOI), a subsidiary of NEC Corporation (NEC), and VAXIMM AG, a Swiss/German biotech company focused on developing an…
CSL Behring AG, a wholly-owned subsidiary of global biotechnology leader CSL Limited has announced the definitive notice of the Interim Result of its public tender offer to acquire all publicly held shares of Vifor Pharma Ltd. for USD 179.25 per share as indicated in the offer prospectus of 18 January 2022.
Valneva SE has announced successful completion of the Phase 3 pivotal trial of its single-shot chikungunya vaccine candidate, VLA1553.
Evaxion Biotech has now finalized recruitment for Phase 1/2a clinical trial of EVX-02 in adjuvant melanoma patients.
In this newly created role reporting to the CEO, Dr. Yver will be accountable for the company’s overall development strategy, including scientific, clinical and regulatory matters, and will continue to provide support to research and clinical development teams.
Some pharmaceutical companies are donating money to support people in Ukraine and are condemning the war and violence in Ukraine.…
Abbott stands with the international community condemning the war and the violence in Ukraine against its people, and calls for peace.
The Board of Ovoca Bio, an international biopharmaceutical company focusing on women’s health, has issued a statement in response to events in Ukraine and Russia.
Tollys has entered into a sponsored research agreement with Gustave Roussy.